Pacira BioSciences, Inc. Common Stock (PCRX) Stock Price

PCRXStock
$25.533.79%52W
Market Cap$1.02B
P/E130.51x
PEG Ratio11.21
Div yield
Beta0.23

PCRX Share Price Chart

Favorite Metrics

Price vs S&P 500 (26W)-3.25%
Price vs S&P 500 (4W)-10.33%
PEG Ratio11.21
VGM Score57.82
P/E Ratio (Annual)130.51x

PCRX Earnings Surprise History

Q2 250.74est. 0.71
Q3 250.70est. 0.65
Q4 250.57est. 0.90
Q1 260.60est. 0.56
Q2 260.73est. 0.65

PCRX Analyst Recommendations

May 2026
Jun 2026
Jul 2026
Aug 2026
3.85
3.85
3.83
3.83

Industry Peers — Pharmaceuticals(571)

SymbolValue ScoreGrowth ScoreMomentum ScorePrice
PCRXPacira BioSciences, Inc. Common Stock
BCC$25.53
LLYEli Lilly & Co.DBB$1233.66
JNJJohnson & JohnsonDCB$273.14
ABBVABBVIE INC.DCB$265.79
MRKMerck & Co., Inc.DCA$156.45
NVSNovartis AGCCC$159.98
AZNAstraZeneca PLCCBC$169.66
NVONovo-Nordisk A/SBCC$48.66
ABTAbbott LaboratoriesCCB$116.13
PFEPfizer Inc.CDC$28.57
VRTXVertex Pharmaceuticals IncDCB$552.85

About Pacira BioSciences, Inc. Common Stock

Pacira BioSciences develops and commercializes non-opioid pain management and regenerative health solutions. The company's marketed products include EXPAREL for postsurgical pain management, ZILRETTA for osteoarthritis, and iovera, a handheld device providing drug-free pain relief through controlled cold therapy. Pacira is also advancing PCRX-201, a gene therapy candidate for knee osteoarthritis.